⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT June 1, 2026

Benlysta 200 mg Injektionslösung im Fertigpen 200 mg (Injektionslösung im Fertigpen)

📷 Wikipedia: Belimumab · Source
Benlysta 200 mg Injektionslösung im Fertigpen 200 mg (Injektionslösung im Fertigpen)
📷 Wikipedia: Belimumab · Source
Benlysta 200 mg injection solution in pre-filled pen
✅
Resolved by agency
The issuing agency has confirmed this medicine alert is over — the underlying issue was addressed. Originally reported 102 days ago.
📈 Timeline
16 days in total
June 2, 2026 June 18, 2026

What is this? Benlysta is a medicine given by injection. It comes in a ready-to-use pen.

What's happening? One pack size (1 pen) is out of stock. The larger pack (4 pens) is still available.

Does this affect me? If you use the 1-pen pack, you may need to wait or switch to the 4-pen pack.

What should I do? Ask your pharmacist or doctor for help finding the right pack for you.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
BELIMUMAB
Agency-published detail

Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: Glaxosmithkline (Ireland) Limited, 12 Riverwalk Citywest Business Campus -, D24 YK11 Dublin 24, Irland · Affected packs: 1 Stück Schachtel, Fertigpen [Nicht verfügbar, since 2026-05-29, resupply 2026-06-20] · 4 Stück Schachtel, Fertigpen [verfügbar]

First published
June 1, 2026
Last refreshed by us
2 months ago
Severity (as classified)
Low
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Benlysta 200 mg Injektionslösung im Fertigpen 200 mg (Injektionslösung im Fertigpen). Benlysta 200 mg injection solution in pre-filled pen
▸ When was this alert issued?
This alert was issued on June 1, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Low risk. A low risk means harm is unlikely under normal use. The alert is informational but still worth reading.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.